Dominguez-Molina, BeatrizTarancon-Diez, LauraHua, StephaneAbad-Molina, CristinaRodriguez-Gallego, EstherMachmach, KawtharVidal, FrancescTural, CristinaMoreno, SantiagoGoni, Maria Josede Arellano, Elena Ramirezdel Val, MargaritaGonzalez-Escribano, Maria FranciscaDel Romero, JorgeRodriguez, CarmenCapa, LauraViciana, PompeyoAlcami, JoseYu, Xu G.Walker, Bruce D.Leal, ManuelLichterfeld, MathiasRuiz-Mateos, EzequielSpanish AIDS Res Network HIV-Contr2023-02-122023-02-122017-03-011058-4838http://hdl.handle.net/10668/18938Background. Human immunodeficiency virus type 1 (HIV-1) controllers maintain HIV-1 viremia at low levels (normally 500 cells/mm(3) for more than 7 years after HIV-1 diagnosis) vs non-LTNP-Cs who developed CD4+ T-cell countsenHIV controllersprogressionHLA-B(star)57IFNL4Plasmacytoid dendritic cellsEliteIl28bClearanceTherapyHLA-B(star)57 and IFNL4-Related Polymorphisms Are Associated With Protection Against HIV-1 Disease Progression in Controllersresearch articleopen access10.1093/cid/ciw8331537-6591https://academic.oup.com/cid/article-pdf/64/5/621/24254783/ciw833.pdf397303400012